Lanean...

Management of Two Cases of Recurrent Anal Carcinoma

Due to the low incidence of anal cancer and generally high cure rates, few second-line treatment options have been evaluated in the setting of formal clinical trials. We briefly report two cases that were both found to have wild-type K-RAS, with no epidermal growth factor receptor amplification or e...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Klimant, Eiko, Markman, Maurie
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: S. Karger AG 2013
Gaiak:
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3806681/
https://ncbi.nlm.nih.gov/pubmed/24163660
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000355004
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!